Regulatory alerts
NICE updates guidelines following a Public Health England evidence review on dependence on, and withdrawal from, prescribed medicines
Updates included in osteoarthritis, peripheral arterial disease, and low back pain and sciatica guidelines.
NICE updates guidelines following MHRA Drug Safety Update on insulins
Updates included in eating disorders, pancreatitis and diabetes guidelines.
![Class 4 Medicines Defect Information: Generics [UK] Limited t/a Mylan, perindopril erbumine](https://images.zapnito.com/users/336911/documents/104236/98030cfd-9c10-4cd4-a55e-566082d52c39-med.jpg)
Erenumab recommended for migraine prevention in final draft guidance
This decision comes after NICE was asked to look at the guidance again when an appeal was lodged against an earlier draft.
